[Federal Register Volume 84, Number 65 (Thursday, April 4, 2019)]
[Notices]
[Pages 13294-13295]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06607]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment (CHACHSPT)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
and the Health Resources and Services Administration (HRSA), announce 
the following meeting for the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment (CHACHSPT). This meeting is 
open to the public, limited only by 90 seats and 70 ports for audio 
phone lines. Time will be available for public comment. The public is 
welcome to submit written comments in advance of the meeting. Comments 
should be submitted in writing by email to the contact person listed 
below. The deadline for receipts is Monday, May 13, 2019. Persons who 
desire to make an oral statement, may request it at the time of the 
public comments period on May 14, 2019 at 4:30 p.m., EDT.

DATES: The meeting will be held on May 14, 2019, 8:30 a.m. to 5:30 
p.m., EDT and May 15, 2019, 8:30 a.m. to 12:30 p.m., EDT.

ADDRESSES: CDC Corporate Square, Building 8, Conference Room 1-ABC, 8 
Corporate Boulevard, Atlanta, Georgia 30329 and Web conference: 1-877-
603-4228, Participant code: 42598858 and https://adobeconnect.cdc.gov/chac/.

FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee 
Management Specialist, CDC, 1600 Clifton Road NE, Mailstop: E-07, 
Atlanta, Georgia 30329-4027, telephone (404) 639-8317; [email protected].

SUPPLEMENTARY INFORMATION:
    Purpose: This committee is charged with advising the Director, CDC 
and the Administrator, HRSA, regarding activities related to prevention 
and control of HIV/AIDS, Viral Hepatitis and other STDs, the support of 
health care services to persons living with HIV/AIDS, and education of 
health

[[Page 13295]]

professionals and the public about HIV/AIDS, Viral Hepatitis and other 
STDs.
    Matters To Be Considered: The agenda will include discussions on 
(1) Prevention of Perinatal HIV, Viral Hepatitis, and Congenital 
Syphilis: Examples from the Field; (2) Ending the HIV Epidemic--
Collaborating Across Geographic Boundaries and Responsibilities; (3) 
Hepatitis C Virus (HCV) Elimination: Institutional Models; (4) Dating 
Apps and STD/HIV Risk: Opportunities for Promotion, Prevention, 
Monitoring and Evaluation; and (5) Updates from Workgroups. Agenda 
items are subject to change as priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-06607 Filed 4-3-19; 8:45 am]
 BILLING CODE 4163-19-P